EP0031 clinical trials

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

This study is testing a new medicine called EP0031 for advanced cancers caused by problems with a gene called RET. It aims to see if EP0031 is safe, what side effects it causes, and how well it works, especially for a type of lung cancer called NSCLC.